LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,000 | -72.5% | 161 | -65.0% | 0.00% | – |
| Q3 2022 | $40,000 | +5.3% | 460 | +6.7% | 0.00% | – |
| Q2 2022 | $38,000 | -11.6% | 431 | +11.7% | 0.00% | – |
| Q1 2022 | $43,000 | -14.0% | 386 | +19.1% | 0.00% | – |
| Q4 2021 | $50,000 | +47.1% | 324 | +34.4% | 0.00% | – |
| Q3 2021 | $34,000 | +88.9% | 241 | +74.6% | 0.00% | – |
| Q2 2021 | $18,000 | +125.0% | 138 | +150.9% | 0.00% | – |
| Q1 2021 | $8,000 | -99.5% | 55 | -99.7% | 0.00% | -100.0% |
| Q3 2019 | $1,566,000 | -46.5% | 15,731 | -38.6% | 0.01% | -50.0% |
| Q2 2019 | $2,925,000 | -57.4% | 25,625 | -53.1% | 0.02% | -55.6% |
| Q1 2019 | $6,866,000 | -12.3% | 54,615 | -5.3% | 0.04% | -21.7% |
| Q4 2018 | $7,830,000 | -44.3% | 57,701 | +12.6% | 0.05% | -33.3% |
| Q3 2018 | $14,064,000 | +1.4% | 51,237 | -23.5% | 0.07% | -1.4% |
| Q2 2018 | $13,872,000 | +40.9% | 66,958 | +12.4% | 0.07% | +37.3% |
| Q1 2018 | $9,843,000 | +14.3% | 59,596 | -5.2% | 0.05% | +21.4% |
| Q4 2017 | $8,612,000 | +50.5% | 62,896 | +49.6% | 0.04% | +40.0% |
| Q3 2017 | $5,724,000 | -15.2% | 42,042 | -24.4% | 0.03% | +57.9% |
| Q2 2017 | $6,750,000 | +113.1% | 55,600 | +85.8% | 0.02% | +5.6% |
| Q1 2017 | $3,167,000 | -38.2% | 29,927 | -39.7% | 0.02% | -37.9% |
| Q4 2016 | $5,125,000 | -0.7% | 49,630 | -1.8% | 0.03% | -9.4% |
| Q3 2016 | $5,159,000 | -14.4% | 50,550 | 0.0% | 0.03% | -17.9% |
| Q2 2016 | $6,029,000 | -6.8% | 50,550 | -16.3% | 0.04% | -7.1% |
| Q1 2016 | $6,468,000 | -2.7% | 60,396 | -1.5% | 0.04% | +2.4% |
| Q4 2015 | $6,645,000 | +27.8% | 61,294 | +1.0% | 0.04% | +24.2% |
| Q3 2015 | $5,199,000 | -2.4% | 60,700 | +15.0% | 0.03% | +6.5% |
| Q2 2015 | $5,328,000 | -4.4% | 52,800 | -27.0% | 0.03% | -3.1% |
| Q1 2015 | $5,575,000 | +21.7% | 72,300 | -16.0% | 0.03% | +18.5% |
| Q4 2014 | $4,581,000 | +13.2% | 86,100 | 0.0% | 0.03% | +12.5% |
| Q3 2014 | $4,046,000 | -24.6% | 86,100 | 0.0% | 0.02% | -20.0% |
| Q2 2014 | $5,363,000 | -15.1% | 86,100 | -8.3% | 0.03% | -18.9% |
| Q1 2014 | $6,316,000 | -9.0% | 93,900 | -28.8% | 0.04% | 0.0% |
| Q4 2013 | $6,938,000 | +43.3% | 131,900 | +17.9% | 0.04% | +42.3% |
| Q3 2013 | $4,843,000 | – | 111,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |